Greenwich LifeSciences has shared important updates on the phase 3 Flamingo-01 trial, which is researching GLSI-100, a new immunotherapy for patients with a specific...
Carrick Therapeutics, a company focused on creating new cancer treatments, has recently started a significant study (Phase 1b/2 clinical trial) to test a combination...
A recent clinical trial investigated olaparib's effects on patients with HER2-negative, BRCA-mutated early breast cancer, focusing on fatigue. Results showed temporary tiredness and nausea...
The next phase of an important trial for metastatic triple-negative breast cancer patients is evaluating the effectiveness of trilaciclib combined with chemotherapy.
This effort, officially...
The American Medical Association (AMA) has recently introduced a new Current Procedural Terminology (CPT) code, specifically for the Imagio Breast Imaging System developed by...